Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Website: jnj.com


  • Good financial results growth rate 248.9% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (8.1%)
  • Dividend yield for the last twelve months 3.3%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 0.1% higher than minimum and 22.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (14.2x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: JNJ
Share price, USD:  (-1.5%)144.59
year average price 158.55  


year start price 162.87 2023-05-03

max close price 174.48 2023-07-28

min close price 144.45 2024-04-16

current price 144.59 2024-05-01
Common stocks: 2 631 399 832

Dividend Yield:  3.3%
EV / LTM EBITDA: 14.2x
EV / EBITDA annualized: 13.6x
Last revenue growth (y/y):  -13.6%
Last growth of EBITDA (y/y):  200.0%
Historical revenue growth:  2.9%
Historical growth of EBITDA:  13.2%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 380 474
Net Debt ($m): 32 590
EV (Enterprise Value): 413 064
EBITDA LTM ($m): 29 048
EV / LTM EBITDA: 14.2x
Price to Book: 5.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-04-30MarketBeat

3 Stocks Mega Investors Are Buying

2024-04-29The Motley Fool

Johnson & Johnson Is a King of Dividend Safety

2024-04-28The Motley Fool

2 Top Growth Stocks to Buy Right Now and Hold Forever

2024-04-27The Motley Fool

Johnson & Johnson Stock: Buy, Sell, or Hold?

2024-04-26Zacks Investment Research

Are You Looking for a High-Growth Dividend Stock?

2024-04-26Zacks Investment Research

5 Stocks in Focus on Their Recent Dividend Hike

2024-04-25Seeking Alpha

Bert's March Dividend Income Summary

2024-04-24The Motley Fool

Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

2024-04-22Zacks Investment Research

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

2024-04-20Forbes

Court Orders Johnson & Johnson And Kenvue To Pay $45 Million In Talcum Baby Powder Lawsuit
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data